Ginseng and heme oxygenase-1: The link between an old herb and a new protective system.


Journal

Fitoterapia
ISSN: 1873-6971
Titre abrégé: Fitoterapia
Pays: Netherlands
ID NLM: 16930290R

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 29 08 2019
revised: 04 10 2019
accepted: 05 10 2019
pubmed: 21 10 2019
medline: 24 12 2019
entrez: 21 10 2019
Statut: ppublish

Résumé

Ginseng is an ancient herb, belonging to Asian traditional medicine, that has been considered as a restorative to enhance vitality for centuries. It has been demonstrated that the antioxidant action of ginseng may be mediated through activation of different cellular signaling pathways involving the heme oxygenase (HO) system. Several compounds derived from ginseng have been studied for their potential role in brain, heart and liver protection, and the Nrf2 pathway seems to be the most affected by these natural molecules to exert this effect. Ginseng is also popularly used in cancer patients therapy for the demonstrated capability to defend tissues from chemotherapy-induced damage. Reported results suggest that the effect of ginseng is primarily associated with ROS scavenging, mainly exerted through the activation of Nrf2 pathway, and the consequent induction of HO-1 levels. This review aims to discuss the connection between the antioxidant properties of ginseng and the activation of the HO system, as well as to outline novel therapeutic applications of this medicinal plant to human health.

Identifiants

pubmed: 31629872
pii: S0367-326X(19)31758-7
doi: 10.1016/j.fitote.2019.104370
pii:
doi:

Substances chimiques

Antineoplastic Agents, Phytogenic 0
Antioxidants 0
Cardiotonic Agents 0
Ginsenosides 0
NF-E2-Related Factor 2 0
NFE2L2 protein, human 0
Neuroprotective Agents 0
Phytochemicals 0
HMOX1 protein, human EC 1.14.14.18
Heme Oxygenase-1 EC 1.14.14.18

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

104370

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Giuseppe Carota (G)

Department of Drug Science, Biochemistry Section, University of Catania, 95125 Catania, Italy.

Marco Raffaele (M)

Department of Drug Science, Biochemistry Section, University of Catania, 95125 Catania, Italy.

Valeria Sorrenti (V)

Department of Drug Science, Biochemistry Section, University of Catania, 95125 Catania, Italy.

Loredana Salerno (L)

Department of Drug Science, Medicinal Chemistry Section, University of Catania, 95125 Catania, Italy.

Valeria Pittalà (V)

Department of Drug Science, Medicinal Chemistry Section, University of Catania, 95125 Catania, Italy.

Sebastiano Intagliata (S)

Department of Drug Science, Medicinal Chemistry Section, University of Catania, 95125 Catania, Italy. Electronic address: s.intagliata@unict.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH